Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Magnetic resonance for assessment of axillary lymph node status in early breast cancer: a systematic review and meta-analysis.

Harnan SE, Cooper KL, Meng Y, Ward SE, Fitzgerald P, Papaioannou D, Ingram C, Lorenz E, Wilkinson ID, Wyld L.

Eur J Surg Oncol. 2011 Nov;37(11):928-36. doi: 10.1016/j.ejso.2011.07.007. Epub 2011 Aug 19. Review.

PMID:
21855267
2.

Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation.

Cooper KL, Meng Y, Harnan S, Ward SE, Fitzgerald P, Papaioannou D, Wyld L, Ingram C, Wilkinson ID, Lorenz E.

Health Technol Assess. 2011 Jan;15(4):iii-iv, 1-134. doi: 10.3310/hta15040. Review.

3.

Detection of lymph node metastases by gadolinium-enhanced magnetic resonance imaging: systematic review and meta-analysis.

Klerkx WM, Bax L, Veldhuis WB, Heintz AP, Mali WP, Peeters PH, Moons KG.

J Natl Cancer Inst. 2010 Feb 24;102(4):244-53. doi: 10.1093/jnci/djp514. Epub 2010 Feb 1. Review.

PMID:
20124189
4.

Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer.

Rockall AG, Sohaib SA, Harisinghani MG, Babar SA, Singh N, Jeyarajah AR, Oram DH, Jacobs IJ, Shepherd JH, Reznek RH.

J Clin Oncol. 2005 Apr 20;23(12):2813-21. Erratum in: J Clin Oncol. 2005 Jul 20;23(21):4808.

PMID:
15837995
5.

Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.

Gipponi M, Bassetti C, Canavese G, Catturich A, Di Somma C, Vecchio C, Nicolò G, Schenone F, Tomei D, Cafiero F.

J Surg Oncol. 2004 Mar;85(3):102-11. Review.

PMID:
14991881
6.

Can breast MRI predict axillary lymph node metastasis in women undergoing neoadjuvant chemotherapy.

Javid S, Segara D, Lotfi P, Raza S, Golshan M.

Ann Surg Oncol. 2010 Jul;17(7):1841-6. doi: 10.1245/s10434-010-0934-2. Epub 2010 Feb 9.

PMID:
20143266
7.

A prospective evaluation of positron emission tomography scanning, sentinel lymph node biopsy, and standard axillary dissection for axillary staging in patients with early stage breast cancer.

Lovrics PJ, Chen V, Coates G, Cornacchi SD, Goldsmith CH, Law C, Levine MN, Sanders K, Tandan VR.

Ann Surg Oncol. 2004 Sep;11(9):846-53. Epub 2004 Aug 16.

PMID:
15313737
8.

Evaluation of lymph node metastases of breast cancer using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.

Harada T, Tanigawa N, Matsuki M, Nohara T, Narabayashi I.

Eur J Radiol. 2007 Sep;63(3):401-7. Epub 2007 Mar 29.

PMID:
17398053
9.

MRI and FDG-PET/CT based assessment of axillary lymph node metastasis in early breast cancer: a meta-analysis.

Liang X, Yu J, Wen B, Xie J, Cai Q, Yang Q.

Clin Radiol. 2017 Apr;72(4):295-301. doi: 10.1016/j.crad.2016.12.001. Epub 2017 Jan 27.

PMID:
28139203
10.

[Usefulness of dynamic MR mammography for diagnosis of axillary lymph node status in breast cancer patient].

Enya M, Goto H, Nandate Y, Kiryu T, Kanematsu M, Hoshi H.

Nihon Igaku Hoshasen Gakkai Zasshi. 2000 Nov;60(13):764-70. Japanese.

PMID:
11140326
11.

Continued axillary sampling is unnecessary and provides no further information to sentinel node biopsy in staging breast cancer.

Gui GP, Joubert DJ, Reichert R, Ward A, Lakhani S, Osin P, Nerurkar A, A'Hern R, Benson K, Underwood SR.

Eur J Surg Oncol. 2005 Sep;31(7):707-14.

PMID:
15993028
12.

Diagnostic accuracy of tests for lymph node status in primary cervical cancer: a systematic review and meta-analysis.

Selman TJ, Mann C, Zamora J, Appleyard TL, Khan K.

CMAJ. 2008 Mar 25;178(7):855-62. doi: 10.1503/cmaj.071124. Review.

13.

Magnetic resonance imaging for axillary staging in patients with breast cancer.

Mortellaro VE, Marshall J, Singer L, Hochwald SN, Chang M, Copeland EM, Grobmyer SR.

J Magn Reson Imaging. 2009 Aug;30(2):309-12. doi: 10.1002/jmri.21802.

PMID:
19466713
14.

Three-axillary lymph node sampling for the prediction of nonsentinel node metastases in breast cancer patients with sentinel node metastases.

Motomura K, Egawa C, Komoike Y, Nagumo S, Koyama H, Inaji H.

Ann Surg Oncol. 2006 Jul;13(7):985-9. Epub 2006 May 18.

PMID:
16788761
15.

Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastases.

de Boer M, van Dijck JA, Bult P, Borm GF, Tjan-Heijnen VC.

J Natl Cancer Inst. 2010 Mar 17;102(6):410-25. doi: 10.1093/jnci/djq008. Epub 2010 Feb 26. Review.

PMID:
20190185
16.

Potential of magnetic resonance spectroscopy to detect metastasis in axillary lymph nodes in breast cancer.

Seenu V, Pavan Kumar MN, Sharma U, Gupta SD, Mehta SN, Jagannathan NR.

Magn Reson Imaging. 2005 Dec;23(10):1005-10. Epub 2005 Nov 28.

PMID:
16376185
17.

Positron emission tomography (PET) for assessment of axillary lymph node status in early breast cancer: A systematic review and meta-analysis.

Cooper KL, Harnan S, Meng Y, Ward SE, Fitzgerald P, Papaioannou D, Wyld L, Ingram C, Wilkinson ID, Lorenz E.

Eur J Surg Oncol. 2011 Mar;37(3):187-98. doi: 10.1016/j.ejso.2011.01.003. Epub 2011 Jan 26. Review.

PMID:
21269795
19.

Probability of axillary lymph node metastasis when sentinel lymph node biopsy is negative in women with clinically node negative breast cancer: a Bayesian approach.

Okamoto T, Yamazaki K, Kanbe M, Kodama H, Omi Y, Kawamata A, Suzuki R, Igari Y, Tanaka R, Iihara M, Ito Y, Sawada T, Nishikawa T, Maki M, Kusakabe K, Mitsuhashi N, Obara T.

Breast Cancer. 2005;12(3):203-10.

20.

Equivalent cross-relaxation rate imaging of axillary lymph nodes in breast cancer.

Mastsushima S, Nishiofuku H, Iwata H, Era S, Inaba Y, Kinosada Y.

J Magn Reson Imaging. 2008 Jun;27(6):1278-83. doi: 10.1002/jmri.21355.

PMID:
18504747

Supplemental Content

Support Center